Advertisement
Table 1 Associations between miR-451 expression and clinical characteristics in patients with nasopharyngeal carcinoma
| Characteristics | No. of patients | Expression of miR-451 | P value | |
|---|---|---|---|---|
| Low, n (%) | High, n (%) | |||
| Age | ||||
| ≤ 45 yr | 136 | 66 (47) | 70 (50) | 0.63 |
| > 45 yr | 144 | 74 (53) | 70 (50) | |
| Sex | ||||
| Male | 206 | 100 (71) | 106 (76) | 0.42 |
| Female | 74 | 40 (29) | 34 (24) | |
| WHO Type | ||||
| I + II | 11 | 4 (3) | 7 (5) | 0.36 |
| III | 269 | 136 (97) | 133 (95) | |
| VCA-IgA | ||||
| < 1:80 | 43 | 21 (15) | 22 (16) | 0.87 |
| ≥ 1:80 | 237 | 119 (85) | 118 (84) | |
| EA-IgA | ||||
| < 1:10 | 71 | 37 (26) | 34 (24) | 0.68 |
| ≥ 1:10 | 209 | 103 (74) | 106 (76) | |
| T Stage | ||||
| T1-T2 | 142 | 70 (50) | 72 (51) | 0.81 |
| T3-T4 | 138 | 70 (50) | 68 (49) | |
| N Stage | ||||
| N0 | 42 | 89 (64) | 85 (61) | 0.62 |
| N1-N3 | 238 | 51 (36) | 55 (39) | |
| TNM Stage | ||||
| I-II | 91 | 49 (35) | 42 (30) | 0.37 |
| III-IV | 189 | 91 (65) | 98 (70) | |
